LOCALLY OWNED - INTERNATIONALLY SUPPORTED
We are the local representative of Air Liquide Healthcare, on the Mid North Coast. As an Authorised Agent of the world largest healthcare supplier we are able to offer you world class products with friendly and personalised local service.
Air Liquide Healthcare has been supporting residents of the Mid North Coast for over a decade, providing oxygen therapy and respiratory health products to people suffering from a range of conditions that cause a shortage of oxygen in your body and you may need ‘extra’ oxygen to keep healthy and active.
MEDICAL OXYGEN THERAPY
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Chronic Obstructive Pulmonary Disease (COPD) is the most common lung disease that can be effectively treated with oxygen therapy.
COPD is an umbrella term for two of the major breathing diseases that cause airways to become obstructed – chronic bronchitis and emphysema.
If you suffer from COPD, you are not alone, One in seven Australians over 40 years of age has airflow limitation of their lungs.1
The main symptom of COPD is breathlessness, which often gets worse over time – in the beginning it may occur during activity but later it may happen when you are resting.
Tobacco smoke is the major cause of COPD (2-3-4), although indoor and outdoor air pollution and exposure to pollutants in the workplace are also risk factors.
OTHER ASSOCIATED HEALTH CONDITIONS
Airflow limitation and inflamed lungs can produce too much mucus, leading to coughing and shortness of breath.
Enlarged air sacs in the lungs don’t allow the oxygen and carbon dioxide to move in and out of the lungs to your bloodstream.
This can interfere with signals to your diaphragm and its correct function.
This might interfere with blood being pumped to and from your lungs correctly.
BENEFITS OF OXYGEN THERAPY
Oxygen is a medicine. Oxygen therapy increases the oxygen in your blood and provides a range of benefits that include (5-6):
Feeling less tired and less short of breath
Increased ability to move about and to keep a social life
Increased sleep and quality of life
Improved heart function
References: 1. ToelleToelle B, Xuan W, Bird T, Abramson M, Burton D, Hunter M, Johns D, Maguire G, Wood-Baker R, Marks G: COPD in the Australian burden of lung disease (BOLD) study. Respirology 2011;16 (Suppl 1):12, 2. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the diagnosis management and prevention of chronic obstructive pulmonary disease. Updated 2014; available at http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Oct30.pdf, 3.ERS. Chronic obstructive pulmonary disease in: European lung white book. available at http://www.erswhitebook.org/chapters/chronic-obstructive-pulmonary-disease, 4. WHO, Chronic obstructive pulmonary disease (COPD), Fact sheet N°315, January 2015. Available athttp://www.who.int/mediacentre/factsheets/fs315/fr/; consulted on 05/11/2014 B, Xuan . 5. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980; 93: 391-398, 6. Report of the Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1: 681-686
RESPIRATORY HEALTH PRODUCTS
Portable Oxygen Concentrators
Mucus Clearing Devices
Unit 5, 10 Bellbowrie Street
Bellbowrie Park Business Centre
Port Macquarie NSW 2444
Tel: 02 6583 6728
Fax: 02 6526 2199
Mon - Thurs: 9am - 4pm
Friday - 9am - 12 noon
Saturday: By Appointment